{"gene":"BLVRB","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":1995,"finding":"The BLVRB gene was chromosomally mapped to human chromosome 19q13.13→q13.2 by fluorescence in situ hybridization, using a 0.76-kb cDNA fragment isolated from a human liver cDNA library.","method":"Fluorescence in situ hybridization (FISH)","journal":"Cytogenetics and cell genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct chromosomal localization by FISH, single lab, single method","pmids":["7656592"],"is_preprint":false},{"year":2016,"finding":"BLVRB encodes an NADPH-dependent biliverdin IXβ reductase; a loss-of-function mutation (S111L) within the substrate/cofactor [α/β dinucleotide NAD(P)H] binding fold abolishes flavin and biliverdin IXβ tetrapyrrole redox activity, resulting in exaggerated reactive oxygen species accumulation and enhanced megakaryocytopoiesis/thrombopoiesis.","method":"Platelet transcriptome sequencing, thrombocytosis cohort analysis, in vitro redox activity assays with mutant BLVRB(S111L), ROS measurement","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — enzymatic activity characterized in vitro with mutagenesis, combined with human genetic and cellular phenotypic data; multiple orthogonal methods in one study","pmids":["27207795"],"is_preprint":false},{"year":2020,"finding":"In mice, Blvrb is dispensable for steady-state hematopoiesis but provides a cytoprotective function during stress hematopoiesis; Blvrb-deficient mice show defective stress erythropoiesis and megakaryocyte-biased hematopoietic recovery, with defective lipid peroxidation as a marker of oxidant mishandling, and cell-autonomous megakaryocyte lineage bias documented by multipotential progenitor assays.","method":"Blvrb knockout mice, stress hematopoiesis models, multipotential progenitor assays, lipid peroxidation assays, bone marrow/spleen analysis","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple orthogonal in vivo and in vitro readouts, replicated across multiple assays in one study","pmids":["33359909"],"is_preprint":false},{"year":2025,"finding":"Small-molecule inhibitors of BLVRB's active site (confirmed by NMR spectroscopy and co-crystallization) promote megakaryocyte speciation in biphenotypic erythro/megakaryocyte cellular models and synergize with TPO-dependent megakaryocyte formation in hematopoietic stem cells; oral delivery in mice expands platelet recovery in stress thrombopoietic models.","method":"NMR spectroscopy, co-crystallization, in vitro small-molecule inhibitor screening, megakaryocyte differentiation assays, in vivo oral delivery in stress thrombopoiesis mouse models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — active-site binding confirmed by NMR and co-crystal structure, functional validation in cellular and in vivo models with multiple orthogonal methods","pmids":["40216753"],"is_preprint":false},{"year":2025,"finding":"BLVRB interacts with the N-terminal cytosolic domain of Band 3 (SLC4A1) in red blood cells under normoxia and dissociates under hypoxia; BLVRB Cys109 acts as a nitric oxide relay that trans-nitrosates the glycolytic enzyme GAPDH at active site Cys152, inhibiting glycolytic activity; this oxygen-sensitive switch coordinates redox and glycolytic remodeling in RBCs.","method":"Deep proteomics of ultra-pure RBCs, cross-linking interactomics, biochemical in vitro S-nitrosation assays, humanized mice with Band 3 N-terminus truncation (exercise tolerance, 2,3-BPG synthesis, glycolytic activation assays)","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cross-linking interactomics plus in vitro biochemical assays and humanized mouse model; single lab but multiple orthogonal methods; some mechanistic details (trans-nitrosation) rely on in vitro biochemistry without full mutagenesis validation described in abstract","pmids":["42224377"],"is_preprint":false}],"current_model":"BLVRB is an NADPH-dependent biliverdin IXβ reductase whose active site binds flavin and biliverdin IXβ tetrapyrroles; loss of its redox activity (e.g., via the S111L mutation) causes ROS accumulation that drives enhanced megakaryocytopoiesis and thrombopoiesis, while in red blood cells BLVRB forms an oxygen-sensitive complex with Band 3 (SLC4A1) at normoxia and, via Cys109-mediated S-nitrosation of GAPDH Cys152, regulates glycolytic flux during hypoxic adaptation."},"narrative":{"mechanistic_narrative":"BLVRB is an NADPH-dependent biliverdin IXβ reductase that functions as a cytoprotective redox enzyme governing the balance between erythroid and megakaryocyte lineage commitment in hematopoiesis [PMID:27207795, PMID:33359909]. Its active site engages flavin and biliverdin IXβ tetrapyrrole substrates within an α/β dinucleotide NAD(P)H-binding fold, and the loss-of-function S111L mutation abolishes this redox activity, causing reactive oxygen species accumulation that drives exaggerated megakaryocytopoiesis and thrombopoiesis [PMID:27207795]. Genetic ablation in mice establishes that BLVRB is dispensable for steady-state hematopoiesis but is required during stress hematopoiesis, where its absence produces defective stress erythropoiesis, megakaryocyte-biased recovery, and defective lipid peroxidation indicative of oxidant mishandling [PMID:33359909]. Active-site binding has been resolved by NMR and co-crystallography, and small-molecule inhibitors of this site promote megakaryocyte speciation and expand platelet recovery in vivo, positioning BLVRB as a druggable node in thrombopoiesis [PMID:40216753]. In red blood cells BLVRB additionally forms an oxygen-sensitive complex with the N-terminal cytosolic domain of Band 3 (SLC4A1) at normoxia that dissociates under hypoxia, and BLVRB Cys109 relays nitric oxide to trans-nitrosate GAPDH at Cys152 to inhibit glycolysis, coordinating redox and glycolytic remodeling during hypoxic adaptation [PMID:42224377].","teleology":[{"year":1995,"claim":"Establishing the genomic location of BLVRB was the first step toward defining it as a discrete human gene amenable to functional and genetic study.","evidence":"FISH mapping using a liver cDNA fragment","pmids":["7656592"],"confidence":"Medium","gaps":["No functional or enzymatic role assigned","No tissue expression or phenotype linkage","Single method, single lab"]},{"year":2016,"claim":"Identifying BLVRB as an NADPH-dependent biliverdin IXβ reductase and linking its loss-of-function S111L mutation to ROS-driven thrombopoiesis converted a mapped gene into a defined redox enzyme controlling megakaryocyte output.","evidence":"Platelet transcriptome sequencing, thrombocytosis cohort analysis, and in vitro redox assays with BLVRB(S111L)","pmids":["27207795"],"confidence":"High","gaps":["In vivo requirement for the enzyme not yet tested by genetic ablation","Mechanism linking ROS accumulation to lineage bias not resolved","Physiological tetrapyrrole substrate flux unquantified"]},{"year":2020,"claim":"Knockout mice resolved whether BLVRB is constitutively required versus stress-specific, showing it is dispensable at steady state but cytoprotective during stress hematopoiesis.","evidence":"Blvrb knockout mice with stress hematopoiesis models, multipotential progenitor assays, and lipid peroxidation readouts","pmids":["33359909"],"confidence":"High","gaps":["Molecular trigger that activates BLVRB cytoprotection under stress unknown","Link between lipid peroxidation defect and lineage bias not mechanistically dissected","Relationship to the human S111L phenotype not directly reconciled"]},{"year":2025,"claim":"Structural confirmation of the active site and pharmacological inhibition demonstrated that targeting BLVRB enzymatic activity can be exploited to expand platelet production therapeutically.","evidence":"NMR, co-crystallization, inhibitor screening, megakaryocyte differentiation assays, and oral delivery in stress thrombopoiesis mice","pmids":["40216753"],"confidence":"High","gaps":["Selectivity and off-target profile of inhibitors not detailed","Whether inhibition phenocopies S111L mechanistically not established","Long-term safety of redox enzyme inhibition unaddressed"]},{"year":2025,"claim":"Discovery of an oxygen-sensitive BLVRB–Band 3 complex and a Cys109-mediated trans-nitrosation of GAPDH extended BLVRB function beyond hematopoietic redox control to glycolytic regulation in mature red cells.","evidence":"Deep RBC proteomics, cross-linking interactomics, in vitro S-nitrosation assays, and humanized Band 3 N-terminal truncation mice","pmids":["42224377"],"confidence":"Medium","gaps":["Trans-nitrosation mechanism relies on in vitro biochemistry without full mutagenesis validation","Quantitative contribution to hypoxic glycolytic flux in vivo unclear","Reciprocal structural detail of the Band 3 interface not resolved"]},{"year":null,"claim":"How BLVRB's enzymatic redox activity, its Band 3 interaction, and its NO-relay function are integrated into a single physiological program across erythroid and megakaryocyte lineages remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking tetrapyrrole reductase activity to the GAPDH trans-nitrosation function","Mechanism coupling ROS handling to lineage decision-making unknown","In vivo significance of the oxygen-sensitive switch for tissue oxygen delivery untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[1,2]},{"term_id":"GO:0016209","term_label":"antioxidant activity","supporting_discovery_ids":[1,2]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[4]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[1,2,3]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[2,4]}],"complexes":[],"partners":["SLC4A1","GAPDH"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P30043","full_name":"Flavin reductase (NADPH)","aliases":["Biliverdin reductase B","BVR-B","Biliverdin-IX beta-reductase","Green heme-binding protein","GHBP","NADPH-dependent diaphorase","NADPH-flavin reductase","FLR","S-nitroso-CoA-assisted nitrosyltransferase","SNO-CoA-assisted nitrosyltransferase"],"length_aa":206,"mass_kda":22.1,"function":"Enzyme that can both act as a NAD(P)H-dependent reductase and a S-nitroso-CoA-dependent nitrosyltransferase (PubMed:10620517, PubMed:18241201, PubMed:27207795, PubMed:38056462, PubMed:7929092). Promotes fetal heme degradation during development (PubMed:10858451, PubMed:18241201, PubMed:7929092). Also expressed in adult tissues, where it acts as a regulator of hematopoiesis, intermediary metabolism (glutaminolysis, glycolysis, TCA cycle and pentose phosphate pathway) and insulin signaling (PubMed:27207795, PubMed:29500232, PubMed:38056462). Has a broad specificity oxidoreductase activity by catalyzing the NAD(P)H-dependent reduction of a variety of flavins, such as riboflavin, FAD or FMN, biliverdins, methemoglobin and PQQ (pyrroloquinoline quinone) (PubMed:10620517, PubMed:18241201, PubMed:7929092). Contributes to fetal heme catabolism by catalyzing reduction of biliverdin IXbeta into bilirubin IXbeta in the liver (PubMed:10858451, PubMed:18241201, PubMed:7929092). Biliverdin IXbeta, which constitutes the major heme catabolite in the fetus is not present in adult (PubMed:10858451, PubMed:18241201, PubMed:7929092). Does not reduce bilirubin IXalpha (PubMed:10858451, PubMed:18241201, PubMed:7929092). Can also reduce the complexed Fe(3+) iron to Fe(2+) in the presence of FMN and NADPH (PubMed:10620517). Acts as a protein nitrosyltransferase by catalyzing nitrosylation of cysteine residues of target proteins, such as HMOX2, INSR and IRS1 (PubMed:38056462). S-nitroso-CoA-dependent nitrosyltransferase activity is mediated via a 'ping-pong' mechanism: BLVRB first associates with both S-nitroso-CoA and protein substrate, nitric oxide group is then transferred from S-nitroso-CoA to Cys-109 and Cys-188 residues of BLVRB and from S-nitroso-BLVRB to the protein substrate (PubMed:38056462). Inhibits insulin signaling by mediating nitrosylation of INSR and IRS1, leading to their inhibition (PubMed:38056462)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P30043/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BLVRB","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000090013","cell_line_id":"CID000939","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"ACADM","stoichiometry":0.2},{"gene":"NANS","stoichiometry":0.2},{"gene":"TRAP1","stoichiometry":0.2},{"gene":"NDUFA3","stoichiometry":0.2},{"gene":"COX5A","stoichiometry":0.2},{"gene":"DPYSL2","stoichiometry":0.2},{"gene":"MDH2","stoichiometry":0.2},{"gene":"ETFB","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000939","total_profiled":1310},"omim":[{"mim_id":"600941","title":"BILIVERDIN REDUCTASE B; BLVRB","url":"https://www.omim.org/entry/600941"},{"mim_id":"250700","title":"METHEMOGLOBIN REDUCTASE DEFICIENCY","url":"https://www.omim.org/entry/250700"},{"mim_id":"163890","title":"SYNUCLEIN, ALPHA; SNCA","url":"https://www.omim.org/entry/163890"},{"mim_id":"109750","title":"BILIVERDIN REDUCTASE A; BLVRA","url":"https://www.omim.org/entry/109750"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Vesicles","reliability":"Additional"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":588.8}],"url":"https://www.proteinatlas.org/search/BLVRB"},"hgnc":{"alias_symbol":["SDR43U1"],"prev_symbol":["FLR"]},"alphafold":{"accession":"P30043","domains":[{"cath_id":"3.40.50.720","chopping":"4-201","consensus_level":"high","plddt":98.0717,"start":4,"end":201}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P30043","model_url":"https://alphafold.ebi.ac.uk/files/AF-P30043-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P30043-F1-predicted_aligned_error_v6.png","plddt_mean":97.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BLVRB","jax_strain_url":"https://www.jax.org/strain/search?query=BLVRB"},"sequence":{"accession":"P30043","fasta_url":"https://rest.uniprot.org/uniprotkb/P30043.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P30043/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P30043"}},"corpus_meta":[{"pmid":"30094234","id":"PMC_30094234","title":"Comparison of 2-Aminobenzamide, Procainamide and RapiFluor-MS as Derivatizing Agents for High-Throughput HILIC-UPLC-FLR-MS N-glycan Analysis.","date":"2018","source":"Frontiers in chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30094234","citation_count":95,"is_preprint":false},{"pmid":"27207795","id":"PMC_27207795","title":"BLVRB redox mutation defines heme degradation in a metabolic pathway of enhanced thrombopoiesis in humans.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/27207795","citation_count":37,"is_preprint":false},{"pmid":"19735483","id":"PMC_19735483","title":"FLR-2, the glycoprotein hormone alpha subunit, is involved in the neural control of intestinal functions in Caenorhabditis elegans.","date":"2009","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/19735483","citation_count":27,"is_preprint":false},{"pmid":"8321021","id":"PMC_8321021","title":"Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemias.","date":"1993","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/8321021","citation_count":16,"is_preprint":false},{"pmid":"33359909","id":"PMC_33359909","title":"Divergent erythroid megakaryocyte fates in Blvrb-deficient mice establish non-overlapping cytoprotective functions during stress hematopoiesis.","date":"2020","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33359909","citation_count":15,"is_preprint":false},{"pmid":"15647385","id":"PMC_15647385","title":"FLR-4, a novel serine/threonine protein kinase, regulates defecation rhythm in Caenorhabditis elegans.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15647385","citation_count":14,"is_preprint":false},{"pmid":"37773960","id":"PMC_37773960","title":"Opposing action of the FLR-2 glycoprotein hormone and DRL-1/FLR-4 MAP kinases balance p38-mediated growth and lipid homeostasis in C. elegans.","date":"2023","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/37773960","citation_count":12,"is_preprint":false},{"pmid":"7656592","id":"PMC_7656592","title":"Mapping of the newly identified biliverdin-IX beta reductase gene (BLVRB) to human chromosome 19q13.13-->q13.2 by fluorescence in situ hybridization.","date":"1995","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7656592","citation_count":12,"is_preprint":false},{"pmid":"21518154","id":"PMC_21518154","title":"Ultradian rhythm in the intestine of Caenorhabditis elegans is controlled by the C-terminal region of the FLR-1 ion channel and the hydrophobic domain of the FLR-4 protein kinase.","date":"2011","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/21518154","citation_count":10,"is_preprint":false},{"pmid":"8018414","id":"PMC_8018414","title":"Mutation analysis of RASK and the 'FLR exon' of NF1 in sporadic ovarian carcinoma.","date":"1994","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/8018414","citation_count":6,"is_preprint":false},{"pmid":"37222180","id":"PMC_37222180","title":"IGF1 synthesis after CO2 fractional laser resurfacing (FLR): New insights in the treatment of scalp actinic keratoses.","date":"2023","source":"Lasers in surgery and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37222180","citation_count":5,"is_preprint":false},{"pmid":"9330625","id":"PMC_9330625","title":"On the recovery of single spots with the flr phenotype in the wing spot test in Drosophila.","date":"1997","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/9330625","citation_count":4,"is_preprint":false},{"pmid":"31976902","id":"PMC_31976902","title":"FLR: A Revolutionary Alignment-Free Similarity Analysis Methodology for DNA-Sequences.","date":"2021","source":"IEEE/ACM transactions on computational biology and bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/31976902","citation_count":3,"is_preprint":false},{"pmid":"40216753","id":"PMC_40216753","title":"Small molecule BLVRB redox inhibitor promotes megakaryocytopoiesis and stress thrombopoiesis in vivo.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40216753","citation_count":2,"is_preprint":false},{"pmid":"29371358","id":"PMC_29371358","title":"Whole-Genome Sequences of Zika Virus FLR Strains after Passage in Vero or C6/36 Cells.","date":"2018","source":"Genome announcements","url":"https://pubmed.ncbi.nlm.nih.gov/29371358","citation_count":2,"is_preprint":false},{"pmid":"33908012","id":"PMC_33908012","title":"Profiling, Relative Quantification, and Identification of Sialylated N-Linked Oligosaccharides by UPLC-FLR-ESI/MS After Derivatization with Fluorescent Anthranilamide.","date":"2021","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/33908012","citation_count":1,"is_preprint":false},{"pmid":"38766028","id":"PMC_38766028","title":"The TWK-26/KCNK3 potassium channel and FLR-4 protein kinase coordinate nutrient absorption in the C. elegans intestine.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38766028","citation_count":0,"is_preprint":false},{"pmid":"41700736","id":"PMC_41700736","title":"The TWK-26/KCNK3 potassium channel and FLR-4 protein kinase coordinate nutrient absorption in the C. elegans intestine.","date":"2026","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41700736","citation_count":0,"is_preprint":false},{"pmid":"41394639","id":"PMC_41394639","title":"Deep Red Blood Cell Proteome Defines the Band 3 N-Terminus Interactome as a Regulator of Hypoxic Adaptation via BLVRB-Dependent S -Nitroso Transfer.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41394639","citation_count":0,"is_preprint":false},{"pmid":"42224377","id":"PMC_42224377","title":"The red blood cell proteome and interactome identify a Band 3-BLVRB axis regulating hypoxic metabolic adaptation.","date":"2026","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/42224377","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.12.25327328","title":"Multi-omics data integration from patients with carotid stenosis illuminates key molecular signatures of atherosclerotic instability","date":"2025-05-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.12.25327328","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.15.682640","title":"Reaction kinetics of procainamide dye derivatization of N-linked glycans to enable robust process analytical workflows for glycoprotein-based biologics manufacturing","date":"2025-10-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.15.682640","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.29.691178","title":"Deep Red Blood Cell Proteome Defines the Band 3 N-Terminus Interactome as a Regulator of Hypoxic Adaptation via BLVRB-Dependent  <i>S</i>  -Nitroso Transfer","date":"2025-11-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.29.691178","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13794,"output_tokens":1466,"usd":0.031686,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8203,"output_tokens":2439,"usd":0.050995,"stage2_stop_reason":"end_turn"},"total_usd":0.082681,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"The BLVRB gene was chromosomally mapped to human chromosome 19q13.13→q13.2 by fluorescence in situ hybridization, using a 0.76-kb cDNA fragment isolated from a human liver cDNA library.\",\n      \"method\": \"Fluorescence in situ hybridization (FISH)\",\n      \"journal\": \"Cytogenetics and cell genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct chromosomal localization by FISH, single lab, single method\",\n      \"pmids\": [\"7656592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"BLVRB encodes an NADPH-dependent biliverdin IXβ reductase; a loss-of-function mutation (S111L) within the substrate/cofactor [α/β dinucleotide NAD(P)H] binding fold abolishes flavin and biliverdin IXβ tetrapyrrole redox activity, resulting in exaggerated reactive oxygen species accumulation and enhanced megakaryocytopoiesis/thrombopoiesis.\",\n      \"method\": \"Platelet transcriptome sequencing, thrombocytosis cohort analysis, in vitro redox activity assays with mutant BLVRB(S111L), ROS measurement\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — enzymatic activity characterized in vitro with mutagenesis, combined with human genetic and cellular phenotypic data; multiple orthogonal methods in one study\",\n      \"pmids\": [\"27207795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In mice, Blvrb is dispensable for steady-state hematopoiesis but provides a cytoprotective function during stress hematopoiesis; Blvrb-deficient mice show defective stress erythropoiesis and megakaryocyte-biased hematopoietic recovery, with defective lipid peroxidation as a marker of oxidant mishandling, and cell-autonomous megakaryocyte lineage bias documented by multipotential progenitor assays.\",\n      \"method\": \"Blvrb knockout mice, stress hematopoiesis models, multipotential progenitor assays, lipid peroxidation assays, bone marrow/spleen analysis\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple orthogonal in vivo and in vitro readouts, replicated across multiple assays in one study\",\n      \"pmids\": [\"33359909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Small-molecule inhibitors of BLVRB's active site (confirmed by NMR spectroscopy and co-crystallization) promote megakaryocyte speciation in biphenotypic erythro/megakaryocyte cellular models and synergize with TPO-dependent megakaryocyte formation in hematopoietic stem cells; oral delivery in mice expands platelet recovery in stress thrombopoietic models.\",\n      \"method\": \"NMR spectroscopy, co-crystallization, in vitro small-molecule inhibitor screening, megakaryocyte differentiation assays, in vivo oral delivery in stress thrombopoiesis mouse models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — active-site binding confirmed by NMR and co-crystal structure, functional validation in cellular and in vivo models with multiple orthogonal methods\",\n      \"pmids\": [\"40216753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BLVRB interacts with the N-terminal cytosolic domain of Band 3 (SLC4A1) in red blood cells under normoxia and dissociates under hypoxia; BLVRB Cys109 acts as a nitric oxide relay that trans-nitrosates the glycolytic enzyme GAPDH at active site Cys152, inhibiting glycolytic activity; this oxygen-sensitive switch coordinates redox and glycolytic remodeling in RBCs.\",\n      \"method\": \"Deep proteomics of ultra-pure RBCs, cross-linking interactomics, biochemical in vitro S-nitrosation assays, humanized mice with Band 3 N-terminus truncation (exercise tolerance, 2,3-BPG synthesis, glycolytic activation assays)\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cross-linking interactomics plus in vitro biochemical assays and humanized mouse model; single lab but multiple orthogonal methods; some mechanistic details (trans-nitrosation) rely on in vitro biochemistry without full mutagenesis validation described in abstract\",\n      \"pmids\": [\"42224377\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BLVRB is an NADPH-dependent biliverdin IXβ reductase whose active site binds flavin and biliverdin IXβ tetrapyrroles; loss of its redox activity (e.g., via the S111L mutation) causes ROS accumulation that drives enhanced megakaryocytopoiesis and thrombopoiesis, while in red blood cells BLVRB forms an oxygen-sensitive complex with Band 3 (SLC4A1) at normoxia and, via Cys109-mediated S-nitrosation of GAPDH Cys152, regulates glycolytic flux during hypoxic adaptation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"BLVRB is an NADPH-dependent biliverdin IXβ reductase that functions as a cytoprotective redox enzyme governing the balance between erythroid and megakaryocyte lineage commitment in hematopoiesis [#1, #2]. Its active site engages flavin and biliverdin IXβ tetrapyrrole substrates within an α/β dinucleotide NAD(P)H-binding fold, and the loss-of-function S111L mutation abolishes this redox activity, causing reactive oxygen species accumulation that drives exaggerated megakaryocytopoiesis and thrombopoiesis [#1]. Genetic ablation in mice establishes that BLVRB is dispensable for steady-state hematopoiesis but is required during stress hematopoiesis, where its absence produces defective stress erythropoiesis, megakaryocyte-biased recovery, and defective lipid peroxidation indicative of oxidant mishandling [#2]. Active-site binding has been resolved by NMR and co-crystallography, and small-molecule inhibitors of this site promote megakaryocyte speciation and expand platelet recovery in vivo, positioning BLVRB as a druggable node in thrombopoiesis [#3]. In red blood cells BLVRB additionally forms an oxygen-sensitive complex with the N-terminal cytosolic domain of Band 3 (SLC4A1) at normoxia that dissociates under hypoxia, and BLVRB Cys109 relays nitric oxide to trans-nitrosate GAPDH at Cys152 to inhibit glycolysis, coordinating redox and glycolytic remodeling during hypoxic adaptation [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing the genomic location of BLVRB was the first step toward defining it as a discrete human gene amenable to functional and genetic study.\",\n      \"evidence\": \"FISH mapping using a liver cDNA fragment\",\n      \"pmids\": [\"7656592\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No functional or enzymatic role assigned\",\n        \"No tissue expression or phenotype linkage\",\n        \"Single method, single lab\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identifying BLVRB as an NADPH-dependent biliverdin IXβ reductase and linking its loss-of-function S111L mutation to ROS-driven thrombopoiesis converted a mapped gene into a defined redox enzyme controlling megakaryocyte output.\",\n      \"evidence\": \"Platelet transcriptome sequencing, thrombocytosis cohort analysis, and in vitro redox assays with BLVRB(S111L)\",\n      \"pmids\": [\"27207795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo requirement for the enzyme not yet tested by genetic ablation\",\n        \"Mechanism linking ROS accumulation to lineage bias not resolved\",\n        \"Physiological tetrapyrrole substrate flux unquantified\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Knockout mice resolved whether BLVRB is constitutively required versus stress-specific, showing it is dispensable at steady state but cytoprotective during stress hematopoiesis.\",\n      \"evidence\": \"Blvrb knockout mice with stress hematopoiesis models, multipotential progenitor assays, and lipid peroxidation readouts\",\n      \"pmids\": [\"33359909\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Molecular trigger that activates BLVRB cytoprotection under stress unknown\",\n        \"Link between lipid peroxidation defect and lineage bias not mechanistically dissected\",\n        \"Relationship to the human S111L phenotype not directly reconciled\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Structural confirmation of the active site and pharmacological inhibition demonstrated that targeting BLVRB enzymatic activity can be exploited to expand platelet production therapeutically.\",\n      \"evidence\": \"NMR, co-crystallization, inhibitor screening, megakaryocyte differentiation assays, and oral delivery in stress thrombopoiesis mice\",\n      \"pmids\": [\"40216753\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Selectivity and off-target profile of inhibitors not detailed\",\n        \"Whether inhibition phenocopies S111L mechanistically not established\",\n        \"Long-term safety of redox enzyme inhibition unaddressed\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery of an oxygen-sensitive BLVRB–Band 3 complex and a Cys109-mediated trans-nitrosation of GAPDH extended BLVRB function beyond hematopoietic redox control to glycolytic regulation in mature red cells.\",\n      \"evidence\": \"Deep RBC proteomics, cross-linking interactomics, in vitro S-nitrosation assays, and humanized Band 3 N-terminal truncation mice\",\n      \"pmids\": [\"42224377\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Trans-nitrosation mechanism relies on in vitro biochemistry without full mutagenesis validation\",\n        \"Quantitative contribution to hypoxic glycolytic flux in vivo unclear\",\n        \"Reciprocal structural detail of the Band 3 interface not resolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BLVRB's enzymatic redox activity, its Band 3 interaction, and its NO-relay function are integrated into a single physiological program across erythroid and megakaryocyte lineages remains unresolved.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No unified model linking tetrapyrrole reductase activity to the GAPDH trans-nitrosation function\",\n        \"Mechanism coupling ROS handling to lineage decision-making unknown\",\n        \"In vivo significance of the oxygen-sensitive switch for tissue oxygen delivery untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"GO:0016209\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [1, 2, 3]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"SLC4A1\",\n      \"GAPDH\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":5,"faith_pct":80.0}}